ESLA

Estrella Immunopharma (ESLA)

About Estrella Immunopharma (ESLA)

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.

Details

Daily high

$1.07

Daily low

$0.97

Price at open

$1.00

52 Week High

$3.15

52 Week Low

$0.73

Market cap

43.5M

Dividend yield

0.00%

Volume

72,337

Avg. volume

51,524

P/E ratio

-2.86

Estrella Immunopharma News